Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterisation of Mitochondrial Dysfunction in the ENS in Parkinson’s Disease: A New Target for Early-Diagnostic Markers and Disease Modification
EF 2023-24
Résumé
Parkinson’s Disease (PD) is a complex condition characterized by neuronal loss and ?-synuclein accumulation in the brain. PD is traditionally characterised by movement impairments, however, non-motor signs, such as constipation, may appear years earlier. The Enteric Nervous System (ENS) regulates the gastrointestinal system, including the gut. Studies have found the hallmarks of PD, typically found in the brain, also in the gut. This evidence indicates that the ENS may significantly contribute to the early stages of PD. Therefore, this research project investigates PD with a novel focus on the ENS.
Mitochondria is an organelle responsible for energy production within cells. Mitochondrial dysfunction is evident in PD, affecting not only the brain, but also the gut. Such dysfunction within the ENS could potentially underlie the non-motor symptoms commonly seen in PD. Identifying the role of the ENS in early-stage PD provides pre-diagnostic clues for early intervention, potentially slowing or halting its progression.
I hypothesis that in early PD stages, mitochondrial dysfunction and ?-syn are evident in the ENS; being more pronounced than in the CNS. The research aims to comprehensively examine mitochondrial health in the gut and the brain, using a PD rodent model and human tissue samples. Employing techniques such as immunohistochemistry, which enables precise visualization of mitochondrial structures, and analytical assays, to quantitatively assess PD biomarkers and mitochondrial health.
Identifying individuals in the early, pre-symptomatic stage allows proactive intervention with disease-modifying treatments. This research strives to uncover these connections, enhancing early PD detection and intervention strategies for the benefit of those at risk.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
505843
Name
Al Halabi Lina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterisation of Mitochondrial Dysfunction in the ENS in Parkinson’s Disease: A New Target for Early-Diagnostic Markers and Disease Modification
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Synuclein; Autonomic Symptoms; Disease Modification; Enteric Nervous System; Human Blood Samples (Dna; Mitochondrial Dysfunction; Neurodegenerative Disease Pathology; Parkinson'S Disease; Plasma); Pre-Diagnostic Tool; Rodent Model (Preclinical); Serum
Abstract
Parkinson’s Disease (PD) is a complex condition characterized by neuronal loss and ?-synuclein accumulation in the brain. PD is traditionally characterised by movement impairments, however, non-motor signs, such as constipation, may appear years earlier. The Enteric Nervous System (ENS) regulates the gastrointestinal system, including the gut. Studies have found the hallmarks of PD, typically found in the brain, also in the gut. This evidence indicates that the ENS may significantly contribute to the early stages of PD. Therefore, this research project investigates PD with a novel focus on the ENS.
Mitochondria is an organelle responsible for energy production within cells. Mitochondrial dysfunction is evident in PD, affecting not only the brain, but also the gut. Such dysfunction within the ENS could potentially underlie the non-motor symptoms commonly seen in PD. Identifying the role of the ENS in early-stage PD provides pre-diagnostic clues for early intervention, potentially slowing or halting its progression.
I hypothesis that in early PD stages, mitochondrial dysfunction and ?-syn are evident in the ENS; being more pronounced than in the CNS. The research aims to comprehensively examine mitochondrial health in the gut and the brain, using a PD rodent model and human tissue samples. Employing techniques such as immunohistochemistry, which enables precise visualization of mitochondrial structures, and analytical assays, to quantitatively assess PD biomarkers and mitochondrial health.
Identifying individuals in the early, pre-symptomatic stage allows proactive intervention with disease-modifying treatments. This research strives to uncover these connections, enhancing early PD detection and intervention strategies for the benefit of those at risk.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Al Halabi, Lina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~